IPO Boutique

Endra Life Sciences IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Endra Life Sciences, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Endra Life SciencesNDRAU -
NASDAQ
$5.00-$5.50 $5.00 $5.451.68 million5/9/2017
National Securities, Dougherty & Company
Co-Manager(s):
Health Care
Filing(s):

Filed 2016-11-21
Terms Added 2016-12-06
Updated Prospectus 2017-01-20
Updated Terms 2017-03-27
Updated prospectus 2017-04-18
Underwriters Changed 2017-05-01



Endra Life Sciences Quote & Chart - Click for current quote - NDRAU

About Endra Life Sciences (adapted from Endra Life Sciences prospectus):
They have commercialized an enhanced ultrasound technology for the pre-clinical research market and are leveraging that expertise to develop technology for increasing the capabilities of clinical diagnostic ultrasound, to broaden patient access to the safe diagnosis and treatment of a number of significant medical conditions in circumstances where expensive X-ray computed tomography, or CT, and magnetic resonance imaging, or MRI, technology is unavailable or impractical.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "NDRAU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved